Skip to content

Clinical trials

Completed Phase 2 Intestinal Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intestinal Diseases Phase: Phase 2 Status: Completed Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20041
20081
20103
20141
20161
20172
20181
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2
Menarini Group2
Nihon Pharmaceutical Co., Ltd2
Bausch Health Americas, Inc.1
Catalysis SL1
Facet Biotech1
Furiex Pharmaceuticals, Inc1
Kyowa Kirin, Inc.1
Northwell Health1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intestinal Diseases15
Digestive System Diseases7
Gastrointestinal Diseases7
Colonic Diseases6
Colorectal Neoplasms4
Digestive System Neoplasms4
Gastrointestinal Neoplasms4
Neoplasms4
Rectal Diseases4
Intestinal Neoplasms3

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.